Back in February, newly-confirmed Secretary of Health and & Human Services (HHS) Robert F. Kennedy Jr. promised to reverse decades of industry capture of the public health agencies. Yet, recent moves ...

FDA Commissioner Marty Makary highlighted rapid approvals of the lung cancer drug Zongertinib and the multiple myeloma ...

Food and Drug Administration (FDA) Commissioner Marty Makary recently stated that when it comes to drugs that currently require a prescription, "everything should be over the counter" (OTC) unless ...

Why have so many smart, well-trained doctors stood by as American healthcare descended into a state of profound dysfunction? The answer lies in the gradual, nearly invisible commercial takeover of the ...

ETFs representing global drug companies reached a record high after the U.S. Food and Drug Administration (FDA) announced the appointment of Richard Pazdur, its top cancer drug regulator, as the head ...

Pharmaceutical companies are accused of abusing the patent system to keep drug prices high. Patent manipulation can delay the availability of cheaper generic alternatives for life-saving medications.

After months of threats, President Trump eased up pressure on drugmakers late last year. That’s all it took for investors to notice that the beaten-down sector was actually growing just fine. Talk of ...

A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue to bear the cost. Food and Drug Administration (FDA) Commissioner Marty ...